BSA Adsorption on Titanium Dioxide Nanoparticle Surfaces for Controlling Their Cellular Uptake in Skin Cells.

Nanoparticles (NPs) are continuously being developed for many applications including imaging, biomedicine, and everyday products. It is difficult to avoid contact with NPs such as titanium dioxide (TiO2) NPs, which are widely used in sunscreens. However, the safety of TiO2 NPs for skin contact and inhalation remains controversial. If NPs cannot penetrate the skin, they will be unable to circulate in the bloodstream, accumulate in the body, or cause side effects, ensuring their safety. Therefore, this study aimed to modify TiO2 NP surfaces to inhibit their uptake in skin cells. Inspired by protein corona studies, bovine serum albumin (BSA) was chosen to functionalize TiO2 NP surfaces via physical adsorption. The maximum BSA adsorption occurred at pH 5.0. The physicochemical properties (size, ζ-potential, morphology, ultraviolet (UV) absorption efficiency, and sun protection factor (SPF)) of TiO2-BSA NPs were comparable to those of TiO2 NPs, indicating that these properties did not affect cellular uptake. In the safety evaluation, TiO2 NPs and TiO2-BSA NPs exhibited high biocompatibility with skin cells and no phototoxicity after UVA and UVB irradiation. In the efficacy evaluation, both NPs possessed the same photoprotection abilities, reducing membrane damage and DNA breakage after UVA irradiation. Compared with TiO2 NPs, TiO2-BSA NPs showed substantially reduced skin penetration in Franz diffusion cells (91%) and human immortalized keratinocyte (HaCaT) cells (89%). A qualitative cellular uptake study using transmission electron microscopy and confocal laser scanning microscopy confirmed that TiO2 NPs were more abundant than TiO2-BSA NPs inside the HaCaT cells. These findings indicate that TiO2 surface functionalization with BSA inhibits cellular uptake in skin cells while maintaining safety and UV protection efficacy, which might be extended to other NP-based sunscreens.

Fabrication of Sacha Inchi Oil-Loaded Microcapsules Employing Natural-Templated Lycopodium clavatum Spores and Their Pressure-Stimuli Release Behavior.

Polymeric particles have attracted vast attention for use in various fields, especially as drug carriers and cosmetics, due to their excellent ability to protect active ingredients from the environment until reaching a target site. However, these materials are commonly produced from conventional synthetic polymers, which impose adverse effects on the environment due to their non-degradable nature, leading to waste accumulation and pollution in the ecosystem. This work aims to utilize naturally occurring Lycopodium clavatum spores to encapsulate sacha inchi oil (SIO), which contains active compounds with antioxidant activity, by applying a facile passive loading/solvent diffusion-assisted method. Sequential chemical treatments by acetone, potassium hydroxide, and phosphoric acid were employed to remove native biomolecules from the spores before encapsulation effectively. These are mild and facile processes compared to other synthetic polymeric materials. Scanning electron microscopy and Fourier-transform infrared spectroscopy revealed the clean, intact, and ready-to-use microcapsule spores. After the treatments, the structural morphology of the treated spores remained significantly unchanged compared to the untreated counterparts. With an oil/spore ratio of 0.75:1.00 (SIO@spore-0.75), high encapsulation efficiency and capacity loading values of 51.2 and 29.3%, respectively, were obtained. Using antioxidant assay (DPPH), the IC50 of SIO@spore-0.75 was 5.25 ± 3.04 mg/mL, similar to that of pure SIO (5.51 ± 0.31 mg/mL). Under pressure stimuli (1990 N/cm3, equivalent to a gentle press), a high amount of SIO was released (82%) from the microcapsules within 3 min. At an incubation time of 24 h, cytotoxicity tests showed a high cell viability of 88% at the highest concentration of the microcapsules (10 mg/mL), reflecting biocompatibility. The prepared microcapsules have a high potential for cosmetic applications, especially as functional scrub beads in facial washing products.

Solvent-sensitive nanoparticle-enhanced PCR assay for the detection of enterotoxigenic Escherichia coli.

Stimulus-responsive nanoparticles are among the most utilized nanoscale materials in biomedical applications. As these nanoparticles exhibit a manipulable response to a particular stimulus, such as pH, heat, and organic solvent, they are potential signalling units in diagnostic assays. This study aims to enhance the limit of detection and reduce the turnaround time of magnetic nanoparticle polymerase chain reaction (PCR) enzyme-linked gene assay (MELGA), an advanced PCR-based technique termed the solvent-sensitive nanoparticle (SSNP)-enhanced PCR assay. This technique was proposed to detect pathogenic enterotoxigenic Escherichia coli (ETEC) through applying stimulus-responsive nanoparticles. The SSNPs were elaborated with three main components, including mesoporous silica nanoparticles as a structural unit, organic dye (Nile red) as a payload, and the corresponding organic solvent-sensitive polymer shell as "gatekeeper" (poly(maleic anhydride-alt-methyl vinyl ether, PMAMVE). A suitable organic solvent capable of inducing polymer swelling and dye dissolution was investigated by considering a solubility parameter. Using ethanol, the encapsulated Nile red can diffuse out of the SSNPs faster than other solvents and reach a constant concentration within 15 min. For the PCR inhibition study, various SSNPs concentrations (10-30 µg/reaction) were mixed with the ETEC gene and PCR reagent. The results showed that the particles in this concentration range did not inhibit PCR. By comparing the efficacy of conventional PCR, MELGA, and SSNP-enhanced PCR assay, the proposed technique showed a better detection limit than that of PCR, whereas that of MELGA was the lowest. Moreover, compared to MELGA or conventional PCR, this technique provided remarkably faster results in the postamplification process.

Smaller Is Not Always Better: Large-Size Hollow Polydopamine Particles Act as an Efficient Sun Protection Factor Booster for Sunscreens.

Ultraviolet (UV) radiation from the sun is the most harmful factor for human skin, causing sunburn, melasma, freckles, blemishes, and skin cancer. Sunscreens play a key role in blocking UV absorption on the skin. This study focused on the synthesis of hollow polydopamine (h-PDA), whose structure mimics the naturally occurring melanin in humans, for use as an active ingredient in sunscreens by means of a hard-template-based method. The reactions involve a spontaneous polymerization of a dopamine monomer in the presence of tris(hydroxymethyl)aminomethane (Tris) as a catalyst onto a polystyrene (PS) core template. Different sizes of the PS core (about 280 and 450 nm) and weight ratios of PS/DA were applied to elucidate the effect of the hollow diameter and thickness of the shell on the morphology and absorbance of the synthesized h-PDA. From UV absorption results, it was observed that the synthesized h-PDA particles with a larger core diameter (about 450 nm) and a thin shell thickness (about 57 nm) presented high UV absorption. We found that the structure of the synthesized h-PDA is mainly composed of a mixture of 5,6-dihydroxyindole and indole-5,6-quinone precursors covalently linked together. After blending the h-PDA particles with the base cream, the formulation containing h-PDA with a large void diameter of about 450 nm showed the highest sun protection factor (SPF) of up to 7.43, which is related to % booster of 234.7%. In addition, the h-PDA particles exhibited biocompatibility and cellular uptake in keratinocyte HaCaT cells after 24 h of incubation, indicating the potential to mimic natural melanin in preventing UV-induced DNA damage, which could be safely used as an alternative sunscreen.

A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment.

Iodine-131 meta-iodobenzylguanidine (131I-mIBG) has been utilized as a standard treatment to minimize adverse side effects by targeting therapies to bind to the norepinephrine transporter (NET) expressed on 90% of neuroblastoma cells. However, only a minority of patients who receive 131I-mIBG radiotherapy have clinical responses, and these are usually not curative. In this study, novel ligand-conjugated gold nanoparticles (GNPs) based on mIBG were synthesized and evaluated biologically with neuroblastoma cells in vitro. To induce specific internalization to the tumor cells and utilize it as a model for radioenhancement, 127I-modified mIBG was successfully synthesized and grafted covalently to the surface of carboxylated PEG-GNPs. 49.28% of the novel mIBG derivative was grafted on carboxylated PEG-GNPs. The particles were stable and not toxic to the normal fibroblast cell line, L929, even at the highest concentration tested (1013 NPs per mL) at 24, 48, and 72 h. Moreover, the cellular uptake of the model was decreased significantly in the presence of a NET inhibitor, suggesting that there was specific internalization into neuroblastoma cells line (SH-SY5Y) via the NET. Therefore, this model provides useful guidance toward the design of gold nanomaterials to enhance the efficiency of 131I-mIBG treatment in neuroblastoma patients. However, the investigation of radio-therapeutic efficiency after radioisotope 131I substitution will be further conducted in a radiation safety laboratory using an animal model.